Granahan Investment Management, LLC Arcus Biosciences, Inc. Transaction History
Granahan Investment Management, LLC
- $2.38 Billion
- Q3 2024
A detailed history of Granahan Investment Management, LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Granahan Investment Management, LLC holds 357,838 shares of RCUS stock, worth $4.72 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
357,838
Previous 379,847
5.79%
Holding current value
$4.72 Million
Previous $5.79 Million
5.43%
% of portfolio
0.23%
Previous 0.24%
Shares
13 transactions
Others Institutions Holding RCUS
# of Institutions
195Shares Held
51.7MCall Options Held
236KPut Options Held
141K-
Black Rock Inc. New York, NY9.76MShares$129 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$72.2 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.48MShares$45.9 Million0.48% of portfolio
-
State Street Corp Boston, MA3.01MShares$39.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.44MShares$32.2 Million0.1% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $953M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...